Advertisement
Advertisement

NERV

NERV logo

Minerva Neurosciences Inc

2.03
USD
-0.155
-7.09%
Jan 22, 10:39 UTC -5
Closed
...

Minerva Neurosciences Inc Profile

About

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.

Info & Links

CEO

Remy Luthringer

Headquarters

1500 DISTRICT AVE
BURLINGTON, MA 01803, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.minervaneurosciences.com

Auditor

DELOITTE & TOUCHE LLP

Share holders

38

Employees

9

Minerva Neurosciences Inc Statistics

Valuation Measures

Market Capitalization2

14.19M

Enterprise Value

-12.44M

Enterprise Value/EBITDA(ttm)

0.51

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-30.26%

Return on Assets(ttm)

-6.74%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-24.47M

Net Income Available to Common(ttm)

-3.31M

Diluted EPS(ttm)

-0.44

Share Statistics

Beta (5Y Monthly)

0.11

52-Week Change

-68.82%

S&P 500 52-Week Change

25.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

6.99M

Dividend Yield

0.00%

Float4

6.39M

% Held by Insiders

8.60%

% Held by Institutions

34.56%

Balance Sheet

Total Cash(mrq)

26.63M

Total Cash Per Share(mrq)

3.81

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.23%

Quick Ratio(mrq)

6.23%

Book Value Per Share(mrq)

-3.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.90

Free Cash Flow(ytd)

-14.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement